Back to Search Start Over

Dual Role of the Focal Adhesion Kinase in Small-Cell Lung Cancer [P1.07-028]

Authors :
UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie
UCL - (MGD) Service de pneumologie
UCL - (SLuc) Service de pneumologie
Aboubakar Nana, Frank
Lecocq, Marylène
Ladjemi, Maha
Detry, Bruno
Dupasquier, Sébastien
Massion, Pierre
Sibille, Yves
Pilette, Charles
Ocak, Sebahat
IASLC 17th World Conference on Lung Cancer
UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie
UCL - (MGD) Service de pneumologie
UCL - (SLuc) Service de pneumologie
Aboubakar Nana, Frank
Lecocq, Marylène
Ladjemi, Maha
Detry, Bruno
Dupasquier, Sébastien
Massion, Pierre
Sibille, Yves
Pilette, Charles
Ocak, Sebahat
IASLC 17th World Conference on Lung Cancer
Source :
Journal of Thoracic Oncology, Vol. 12, no.1, p. S713 (2017)
Publication Year :
2017

Abstract

BACKGROUND : Small cell-lung cancer (SCLC) is a devastating illness with five-year overall survival as low as 5%. The molecular steps leading to SCLC development and progression are still poorly understood and this has translated into the absence of targeted therapies. Focal Adhesion Kinase (FAK) is a non-receptor tyrosine kinase which regulates integrin and growth factor signaling pathways involved in cell proliferation, survival, migration, and invasion. FAK is overexpressed and/or activated in many cancers, including SCLC. We hypothesized that FAK overexpression/activation in SCLC contributes to its aggressive behavior and that FAK may represent a therapeutic target in SCLC. [...]

Details

Database :
OAIster
Journal :
Journal of Thoracic Oncology, Vol. 12, no.1, p. S713 (2017)
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1288285496
Document Type :
Electronic Resource